May 25, 2026$448/mo July 13, 2026$448/mo July 20, 2026$448/mo July 27, 2026$448/mo August 3, 2026$448/mo We check the published prices behind this total every Monday
Because Retatrutide has not received FDA approval, commercial insurance plans, Medicare, and most pharmacy benefit programs do not currently provide routine coverage for the medication
Tirzepatide can be injected at any time of day, so time zone shifts within a few hours are irrelevant
Can Microdosing Be Done Safely
HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes
What This Means for Businesses Still Selling RUO GLP-1s Not every RUO seller faces the same level of risk